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In 2009, an estimated 6,300 Iowans will die from cancer,  
14 times the number caused by auto fatalities. Cancer 
and heart disease are the two leading causes of death in 
Iowa. The cancer projections in this report are based upon 
mortality data the State Health Registry of Iowa receives 
from the Iowa Department of Public Health. The Registry 
has been recording the occurrence of cancer in Iowa since 
1973, and is one of fourteen population-based registries and 
three supplementary registries nationwide providing data to 
the National Cancer Institute. With 2009 Cancer in Iowa 
the Registry makes a general report to the public on the 
status of cancer. This report will focus on:
 • a description of the Registry and its goals;
 • cancer estimates for 2009;
 • a special section on sources for cancer data;
 • brief summaries of recent/ongoing research projects;
 • a selected list of publications from 2008.
CANCER IS A REPORTABLE DISEASE AS STATED  
in the Iowa Administrative Code. Cancer data are 
collected by the State Health Registry of Iowa, located at 
The University of Iowa in the College of Public Health’s 
Department of Epidemiology. The staff includes more than 
50 people. Half of them, situated throughout the state, 
regularly visit hospitals, clinics, and medical laboratories  
in Iowa and neighboring states to collect cancer data.  
A follow-up program tracks more than 99 percent of  
the cancer survivors diagnosed since 1973. This program 
provides regular updates for follow-up and survival.  
The Registry maintains the confidentiality of the patients, 
physicians, and hospitals providing data.
In 2009 data will be collected on an estimated 16,000  
new cancers among Iowa residents. In situ cases of bladder 
cancer are included in the estimates for bladder cancer,  
to be in agreement with the definition of reportable cases  
of the Surveillance, Epidemiology, and End Results (SEER) 
Program of the National Cancer Institute.
Since 1973 the Iowa Registry has been funded primarily  
by the SEER Program of the National Cancer Institute.  
Iowa represents rural and Midwestern populations and 
provides data included in many National Cancer Institute 
publications. Beginning in 1990 between 5 and 10 percent 
of the Registry’s annual operating budget has been provided 
by the state of Iowa. Beginning in 2003, the University  
of Iowa has been providing cost-sharing funds. The Registry 
also receives funding through grants and contracts with 
university, state, and national researchers investigating 
cancer-related topics.
The Goals of the 
Registry are to:
•  assemble and report 
measurements of  
cancer incidence,  
survival and mortality 
among Iowans;
• provide information  
on changes over time 
 in the extent of disease  
at diagnosis, therapy, 
 and patient survival;
• promote and conduct 
studies designed to  
identify factors relating  
to cancer etiology, 
prevention and control; 
• respond to requests 
from individuals and 
organizations in the  
state of Iowa for cancer 
data and analyses; 
• provide data and  
expertise for cancer  
research activities  
and educational 
opportunities. 
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Cancer Projections for 2009
Estimated Number of New Cancers in Iowa for 2009
Estimated Number of Cancer Deaths in Iowa for 2009
 
5Cancer Deaths in Females
Type                # of Cancers % of Total
Lung 800 25.8
Breast 420 13.5
Colon & Rectum 350 11.3
Pancreas 180 5.8
Ovary 180 5.8
Non-Hodgkin’s Lymphoma 120 3.9
Leukemia 120 3.9
Uterus 100 3.2
Brain 70 2.3
Kidney & Renal pelvis 70     2.3
All Others 690 22.2
Total 3100
Cancer Deaths in Males
Type                # of Cancers % of Total
Lung 1000 31.3 
Prostate 360 11.2 
Colon & Rectum 280 8.8 
Pancreas 180 5.6 
Leukemia 160 5.0 
Esophagus 140 4.4 
Non-Hodgkin’s Lymphoma 130 4.1 
Bladder 110 3.4 
Kidney & Renal pelvis 110 3.4 
Brain 100 3.1 
All Others 630 19.7
Total 3200
New Cancers in Females
Type                # of Cancers  % of Total 
Breast 2150 27.6
Lung 980 12.6
Colon & Rectum 960 12.3
Uterus 480 6.1
Non-Hodgkin’s Lymphoma 340 4.4
Skin Melanoma 300 3.8
Ovary 240 3.1
Thyroid 220 2.8
Kidney & renal pelvis 220 2.8
Leukemia 210 2.7
All Others 1700 21.8
Total 7800
New Cancers in Males
Type                 # of Cancers % of Total
Prostate 2100  25.6 
Lung 1300 15.9 
Colon & Rectum 860 10.5 
Bladder (invasive and noninvasive)  600 7.3 
Skin Melanoma 360 4.4 
Non-Hodgkin’s Lymphoma 350 4.2 
Kidney & Renal pelvis 330 4.0 
Leukemia 270 3.3 
Oral Cavity 230 2.8 
Pancreas 180 2.2 
All Others 1620 19.8
Total 8200
Fortunately for Iowans, the chances of being diagnosed with many types of cancer can be reduced 
through positive health practices such as smoking cessation, physical exercise, healthful dietary habits, 
and limiting alcohol consumption. Early detection through obtaining recommended screening tests 
and regular health checkups can improve cancer survival.  
Top 10 Types of Cancer in Iowa Estimated for 2009
6Cancer data are available for the state of Iowa over the world wide web at http://www.
public-health.uiowa.edu/shri/. Just click on “Iowa Cancer Data” and you will be taken  
to the page that looks like this:
Data are available for incidence (new cases) as well as for mortality (deaths) for the years 
1973-2005. Usually each summer, these data are updated for the next year. Data can be 
selected by county, cancer site, year, sex, and race, and the corresponding map is then created 
using the Redraw button. 
HELPFUL HINTS
  provides a comparison of the age-adjusted incidence rate for all the counties in the state.
  generates a line graph of the data selected that can be incorporated into reports.  
  creates a report with the age-adjusted incidence rates by cancer site for the county selected.
You can select on a 
county of interest in 
the table shown above 
to view the population, 
number of cases, and 
rates by year for the 
time period selected.
Accessing Iowa Cancer Data
7If you want to be able to compare the state of Iowa to the surrounding states, you can also  
go to State Cancer Profiles, http://statecancerprofiles.cancer.gov/ where you can view incidence 
and mortality rates by state. This is also available from the Iowa Cancer Data webpage by 
clicking on the red icon of the United States next to the map as shown above.  
This website is more structured so data are provided for pre-specified years  
(currently years 2001-2005 only). Selections can be made by state, cancer type, race, and sex. 
This website also provides trend data, maps, screening and risk factor data, and census data.  
If you need more detailed data, you can download SEER*Stat by going to http://seer.cancer.gov/
data/access.html. SEER*Stat is provided free of charge by the National Cancer Institute as a 
powerful tool to address specific questions for which statistics (incidence, prevalence, mortality, 
survival) can be produced for studying the impact of cancer on a population. You can design 
queries to select the data you want for Iowa. 
Risk factor data are often needed for our work in cancer prevention and control. At Cancer  
Control P.L.A.N.E.T. (http://cancercontrolplanet.cancer.gov/) you can find 5 steps to developing  
a comprehensive cancer control plan or program, as well as information by cancer control topic, 
such as diet/nutrition, sun safety, survivorship, or tobacco control. The Iowa Behavioral Risk 
Factor Surveillance System (BRFSS) also has risk factor data available at http://www.idph.state.
ia.us/brfss/. The BRFSS is the largest, continuously conducted, telephone survey in the world.  
It is conducted by states under the guidance of the Center for Disease Control and Prevention.  
The survey is designed to identify and monitor risk factors for chronic diseases and other  
leading causes of death.
The Iowa Consortium for Comprehensive Cancer Control (ICCCC) was formed in 2001 to 
create a comprehensive, statewide cancer plan to address critical cancer problems in the state of 
Iowa. This plan was called Changing the Face of Cancer in Iowa: A State Plan for 2003-2005. 
This plan was updated in 2006 to Reducing the Burden of Cancer in Iowa: A Strategic Plan for 
2006-2011. Information on the consortium can be viewed at http://www.canceriowa.org/.    
If you click on the Cancer 
Information tab shown  
here in the screen shot,  
and then click on Iowa 
Statistical Information,  
you have the option to  
view Iowa Cancer Maps.
8Detailed maps generated by the Geography Department at the University of Iowa can be 
found on this website as noted. Updated maps are also available at http://www.iowa.edu/
iowacancermaps/. The map of colorectal cancer mortality for the years 2000-2005 is  
shown below.    
The University of Iowa’s Holden Comprehensive Cancer Center has a Cancer Information 
Service available at http://www.uihealthcare.com/cis. A toll free number (800-237-1225)  
can be used to address questions that individuals have about cancer. 
Registry data have been 
quite useful for cancer 
research. They assist with 
cancer control research 
relating to prevention, 
screening, early detection, 
treatment, survivorship,  
and quality of life. They 
augment cancer health 
services research. They 
provide for population-based 
hypothesis generation and 
hypothesis testing for the 
further investigation of 
cancer etiology and survival. 
They also assist in the 
collection of biospecimens 
for molecular research.  
9The State Health Registry of Iowa is participating in three dozen funded studies during 2009. 
Brief descriptions of a few of these studies are provided.
Agricultural Health Study
The Agricultural Health Study is a long-term study of agricultural exposures (including pesticides) 
and chronic disease (especially cancer) among commercial pesticide applicators, private pesticide 
applicators, and spouses of private pesticide applicators in Iowa and North Carolina. The study  
is funded primarily by the National Cancer Institute. We are in the 17th year of the study,  
which received renewed funding at the end of 2003 for continuation into 2010. 
In the first five years (1993-1997), 89,658 subjects (58,564 in Iowa and 31,094 in North 
Carolina) were enrolled in the study. This total for Iowa included 31,877 private applicators, 
21,771 spouses of private applicators, and 4,916 commercial applicators. Enrollment consisted  
of completing questionnaires about past exposures and health. The second phase of the study  
for private applicators and their spouses was completed at the end of 2003. It involved a 
telephone interview, a mailed dietary questionnaire, and collection of a cheek cell sample 
from all consenting cohort members. The telephone interview asked about pesticide use since 
enrollment, current farming and work practices, and health changes. The dietary health 
questionnaire asked about cooking practices and types of foods eaten. Cooking practices and 
diet may play a role in cancer and other health conditions. The cheek cells are being used to 
understand possible links between genetics, exposures, and disease. For commercial applicators, 
the second phase of the study was completed at the end of 2005. The study’s third phase began 
in 2005, involves updating information about exposures and health, and is ongoing. 
Since 1997, cohort members have been linked annually to mortality and cancer registry incidence 
databases in both states. In addition, mortality data on the cohort are being obtained from  
the National Death Index. More information about recent results from this study, the study 
background, frequently asked questions, other resources (internet & telephone) for agricultural 
health information, references for publications to date, and information for scientific collaborators 
can be found at the website, www.aghealth.org. The abstract is available for these publications  
at the website. The cancer-related references for some of the recent publications are provided in 
the last section of this report.     
Geographical Information Systems
The State Health Registry of Iowa continues its involvement with research utilizing a geographical 
information system to develop and test a methodology for identifying regions of excess cancer 
burden for breast, colorectal, prostate, cervical and non-Hodgkin’s lymphoma cancers in Iowa.  
In 2008 a project supported by the SEER Rapid Response Projects (PI Professor Gerard Rushton) 
was completed. Graduate student Chetan Tiwari designed a web-based mapping program which 
permits users to request geographically detailed maps of these cancer burdens based on datasets 
held by cancer registries on their secure computer servers. The system is currently undergoing 
beta testing by the New Jersey and Utah cancer registries as well as by a research group in the 
National Cancer Institute. Results will be used to plan more appropriate cancer prevention and 
control programs. 
Research Projects During 2009
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The Registry has also provided data in 2008 for maps on cancer incidence and mortality 
created for use by the Iowa Consortium for Comprehensive Cancer Control. The maps were 
created by Dr. Gerard Rushton, Professor of Geography at the University of Iowa, and graduate 
students Kirsten Beyer, Zunqiu Chen, and David Haynes. These maps can be used for planning 
purposes for cancer prevention and control activities. These maps can be viewed at http://www.
uiowa.edu/iowacancermaps/. Several of these maps were used by graduate student Kirsten Beyer 
in interactions with residents of Storm Lake, IA, where rates of colorectal cancer late-stage 
diagnosis and mortality are high, in an effort to understand community cancer experiences 
and discuss interventions to reduce the local burden of colorectal cancer. Currently, maps of 
temporal changes in the cancer burden in Iowa over the last eight years are being prepared  
and will soon be added to this website. 
A SEER Rapid Response Surveillance Study, “Enhancing the utility of geocoding accuracy 
assessments via regression modeling on geographic characteristics and feature size,” was 
conducted by Dr. Dale Zimmerman, Professor of Statistics at the University of Iowa, with 
assistance from graduate student Jie Li. Geocoding accuracy is important to assess because 
inaccurate geocodes of patients’ addresses make it more difficult to accurately characterize 
and map spatial patterns of cancer incidence, staging, survival, and mortality. In his study, 
Dr. Zimmerman found that local street network characteristics, such as street segment length 
and street density, can affect geocoding accuracy in a systematic manner. Knowledge of these 
variables for a patient’s address may therefore be used to better predict the magnitude of the 
positional error incurred when the address is geocoded.
Iowa Women’s Health Study
This is a population-based cohort of 41,837 Iowa women, aged 55-69 in 1986, who were 
recruited to determine whether diet, body fat distribution and other risk factors were related to 
cancer incidence. Exposure and lifestyle information was collected in a baseline mailed survey 
and subsequently in several follow-up mailed surveys. Mortality and cancer incidence have been 
ascertained since 1986 through linkage to the State Health Registry of Iowa databases and the 
National Death Index. The project has resulted in over 200 publications, some of which 
occurred in 2008 and are listed in the references provided in the last section of this report. 
Non-Hodgkin Lymphoma (NHL)
The State Health Registry of Iowa (SHRI) with researchers at the Mayo Clinic participated  
in a collaborative, population-based case-control study of NHL involving researchers at the 
National Cancer Institute and three other Surveillance, Epidemiology, and End Results (SEER) 
registries. The main objective of the study was to better characterize risk factors for NHL.  
In Iowa, 364 patients newly diagnosed with NHL between July 1, 1998 and June 30, 2000 
were enrolled. A similar number of population controls participated. Blood samples were sought 
from study participants. The SHRI also coordinated the acquisition of pathology reports, slides 
and tissue blocks from all SEER centers. The slides were reviewed to confirm the diagnosis 
of NHL pathologic classification. More recently, we are collaborating with researchers at the 
Mayo Clinic to investigate whether genes with functional, common variant polymorphisms 
involved in immune function and regulation are associated with overall survival from NHL 
among these patients. To achieve this aim, medical record reviews were performed to obtain 
more detailed information on the treatment received for NHL. In addition, NHL patients not 
diagnosed and/or treated at the University of Iowa Hospitals and Clinics or at the Mayo Clinic 
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are being contacted by Registry staff to see if they have a family history of hematopoietic 
cancer. If they do, they are being invited to participate by providing a family history and by 
providing blood samples from themselves and their relatives. These research activities have 
resulted in several publications during 2008. The references for some of these are provided  
in the last section of this report. 
Patterns of Care Studies
SEER Patterns of Care Studies are conducted to satisfy a U.S. Congressional directive to the 
National Cancer Institute to “assess the incorporation of state-of-the-art cancer treatment into 
clinical practice and the extent to which cancer patients receive such treatments and include 
the results in such assessment in the biennial reports.” This year’s Patterns of Care Study will 
involve small cell lung cancer, acute myeloid leukemia, multiple myeloma, and hepatocellular 
carcinoma in adults diagnosed between January 1, 2007 and December 31, 2007. The 
objectives of the SEER Patterns of Care Study are to: 1) describe the use of adjuvant therapy  
in a community setting, 2) characterize the practice patterns in different communities,  
3) describe more completely the use of surgery in the treatment of specific cancers, 4) compare 
the patterns of treatment for cancer over time, 5) compare patterns of care by age and race/
ethnicity, 6) describe effect of co-morbid conditions on treatment, and 7) describe treatment  
by hospital characteristics: i.e. for profit vs. not for profit, teaching vs. non-teaching, etc.  
The SHRI has been involved with these types of studies over the past 20 years. During 2008, 
they have resulted in several publications, which are provided in the last section of this report. 
Pooled Analyses
Today, researchers are increasingly looking to combine their study data with that of other 
studies evaluating similar outcomes. During 2008 these activities resulted in several 
publications, which are listed in the last section of this report, involving breast cancer,  
ovarian cancer, and non-Hodgkin lymphoma. 
   
Race/ethnicity 
For several years, the State Health Registry of Iowa has collaborated with other SEER registries 
to provide more accurate cancer statistics for American Indians. This has involved an ongoing 
project to link records from the State Health Registry of Iowa and other SEER Registries with 
records from the Indian Health Service (IHS). In 2008, this resulted in several publications, 
which are listed in the last section of this report, summarizing the cancer experience of 
American Indians between 1999 and 2004. In these publications, the American Indians 
residing in Iowa were included in the Northern Plains IHS region. 
Second Cancer Studies 
Over the past two decades, the State Health Registry of Iowa has participated in several 
second cancer studies. These have consisted of cohorts with a first cancer of the cervix, ovary, 
testis, uterus, female breast, non-Hodgkin’s lymphoma, or Hodgkin’s disease. They have been 
conducted primarily in collaboration with the Radiation Epidemiology Branch at the National 
Cancer Institute and other registries in North America and Europe. Generally these studies 
evaluate the treatment received for the first cancer and the risk it places on the patient for 
development of a second cancer. They typically involve medical record review and pathology 
material retrieval.  
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The WECARE (Women’s Environmental Cancer and Radiation Epidemiology) Study is 
another example of a second cancer study. This study was designed to examine the interaction 
of gene carrier status and radiation exposure in the etiology of female breast cancer. Data 
collection not only involved medical record review, but also participant interviews and blood 
sample collection.   
Results from the second cancer studies have provided important medical information and  
will continue to do so in the future. Several publications during 2008 involving second cancers  
are provided in the last section of this report.
SEER-Medicare
In the early 1990s, the cancer incidence and survival data from the State Health Registry of 
Iowa were combined with other SEER Registry data and linked to Medicare data. This linked 
data set has been updated on several occasions since and has become an important data 
resource for cancer research regarding epidemiologic and health services research related to 
the diagnosis, treatment and procedures, costs, and survival of cancer patients. Over the years 
many publications have resulted from this linked data set, the authors, titles, and abstracts of 
which can be viewed at http://appliedresearch.cancer.gov/cgi-bin-pubsearch/pubsearch/index.pl.
Cooperative Agreements and Other Registries
The SHRI maintains cooperative agreements with several hospital cancer registries and other 
agencies/entities. Some of the latter include:
	 •	 Iowa	Department	of	Public	Health
	 •	 Iowa	Consortium	for	Comprehensive	Cancer	Control
	 •	 The	University	of	Iowa
  - Center for Health Effects of Environmental Contamination
  - Center for Public Health Statistics
  - Environmental Health Sciences Research Center
  - Health Effectiveness Research Center
  - Holden Comprehensive Cancer Center
  - Iowa Center for Agricultural Safety and Health
  - Injury Prevention Research Center
  - Preventive Intervention Center 
  - Reproductive Molecular Epidemiology Research & Education Program
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